Delphi Management’s Bristol-Myers Squibb BMY Stock Holding History

Delphi Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.34M	Buy	21,549 +816	+4%	+$47.9K	1.27%	38
2021 Q3	$1.23M	Buy	20,733 +611	+3%	+$40.2K	1.26%	24
2021 Q2	$1.34M	Buy	20,122 +235	+1%	+$15.3K	1.28%	25
2021 Q1	$1.25M	Buy	+19,887	New	+$1.24M	1.33%	27
2019 Q3	$1.08M	Sell	21,393 -6,443	-23%	-$303K	1.05%	56
2019 Q2	$1.26M	Sell	27,836 -20	-0.1%	-$932	1.13%	53
2019 Q1	$1.33M	Buy	27,856 +1,483	+6%	+$73.9K	1.23%	44
2018 Q4	$1.37M	Buy	+26,373	New	+$1.42M	1.24%	50

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Delphi Management's BMY Position: Q4 2021 in Review

Delphi Management increased its Bristol-Myers Squibb (BMY) stake by 3.9% in Q4 2021, buying an estimated $47.9K and bringing the position to 21,549 shares worth $1.34M. The position accounts for 1.27% of the portfolio, ranked #38.

Delphi Management first reported a position in BMY in Q4 2018 and has held it in 8 quarters since. The position peaked at $1.37M in Q4 2018. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Delphi Management held 21,549 shares of Bristol-Myers Squibb worth $1.34M as of Q4 2021.
Delphi Management bought 816 Bristol-Myers Squibb shares in Q4 2021, an estimated $47.9K.
Bristol-Myers Squibb made up 1.27% of Delphi Management's portfolio in Q4 2021, its #38 holding.
Delphi Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 8 quarters since.
Delphi Management's Bristol-Myers Squibb position peaked at $1.37M in Q4 2018.
2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Delphi Management's 13F filing for Q4 2021, filed 15 Feb 2022.